Introduction to Biological and Small Molecule Drug Research and Development
Theory and Case Studies
Herausgeber: Ganellin, C Robin; Roberts, Stanley M; Jefferis, Roy
Introduction to Biological and Small Molecule Drug Research and Development
Theory and Case Studies
Herausgeber: Ganellin, C Robin; Roberts, Stanley M; Jefferis, Roy
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Edited by three senior scientists with over 100 years experience in the field.
Andere Kunden interessierten sich auch für
- Jie Jack LiDrug Discovery with Privileged Building Blocks263,99 €
- J. Rick TurnerNew Drug Development205,99 €
- Colloid and Interface Science in Pharmaceutical Research and Development168,99 €
- David B. Weiner / William V. WilliamsBiological Approaches to Rational Drug Design178,99 €
- Organ Specific Drug Delivery and Targeting to the Lungs194,99 €
- Sarfaraz K NiaziBiosimilars and Interchangeable Biologics368,99 €
- Natural Pharmaceuticals and Green Microbial Technology185,99 €
-
-
-
Produktdetails
- Produktdetails
- Verlag: Elsevier Health Sciences
- Seitenzahl: 472
- Erscheinungstermin: 11. Juli 2013
- Englisch
- Abmessung: 241mm x 195mm x 30mm
- Gewicht: 1117g
- ISBN-13: 9780123971760
- ISBN-10: 0123971764
- Artikelnr.: 37070337
- Verlag: Elsevier Health Sciences
- Seitenzahl: 472
- Erscheinungstermin: 11. Juli 2013
- Englisch
- Abmessung: 241mm x 195mm x 30mm
- Gewicht: 1117g
- ISBN-13: 9780123971760
- ISBN-10: 0123971764
- Artikelnr.: 37070337
1. 'Introduction to Enzymes, Receptors and Small Molecule Drugs'
2. Proteins: Structure and
Function
3. The Drug Discovery Process - from Target Selection to
Candidate
4. Introduction to Biopharmaceuticals
5. Similarities and Differences in the Discovery, Development and Use of
Biopharmaceuticals versus Small Molecule
Drugs
6. 'Approaching the Same...Treatment of Diabetes
7. The Structure and Business of Bio/pharmaceutical Companies including the
Management of Risks and Resources
8. Gefitinib
9. Herceptin/T-DM1
10. Erythropoietin (Epogen/Eprex/NeoRecormon)
11. Lysosomal Storage diseases
12. Steroids for HRT
13. Anti-HIV protease inhibitor Darunavir
14. Anti-TNF Agents Remicade/Humira/Enbrel/Cimzia
15. The Cholesterol Lowering Drug - Ezetimibe
2. Proteins: Structure and
Function
3. The Drug Discovery Process - from Target Selection to
Candidate
4. Introduction to Biopharmaceuticals
5. Similarities and Differences in the Discovery, Development and Use of
Biopharmaceuticals versus Small Molecule
Drugs
6. 'Approaching the Same...Treatment of Diabetes
7. The Structure and Business of Bio/pharmaceutical Companies including the
Management of Risks and Resources
8. Gefitinib
9. Herceptin/T-DM1
10. Erythropoietin (Epogen/Eprex/NeoRecormon)
11. Lysosomal Storage diseases
12. Steroids for HRT
13. Anti-HIV protease inhibitor Darunavir
14. Anti-TNF Agents Remicade/Humira/Enbrel/Cimzia
15. The Cholesterol Lowering Drug - Ezetimibe
1. 'Introduction to Enzymes, Receptors and Small Molecule Drugs'
2. Proteins: Structure and
Function
3. The Drug Discovery Process - from Target Selection to
Candidate
4. Introduction to Biopharmaceuticals
5. Similarities and Differences in the Discovery, Development and Use of
Biopharmaceuticals versus Small Molecule
Drugs
6. 'Approaching the Same...Treatment of Diabetes
7. The Structure and Business of Bio/pharmaceutical Companies including the
Management of Risks and Resources
8. Gefitinib
9. Herceptin/T-DM1
10. Erythropoietin (Epogen/Eprex/NeoRecormon)
11. Lysosomal Storage diseases
12. Steroids for HRT
13. Anti-HIV protease inhibitor Darunavir
14. Anti-TNF Agents Remicade/Humira/Enbrel/Cimzia
15. The Cholesterol Lowering Drug - Ezetimibe
2. Proteins: Structure and
Function
3. The Drug Discovery Process - from Target Selection to
Candidate
4. Introduction to Biopharmaceuticals
5. Similarities and Differences in the Discovery, Development and Use of
Biopharmaceuticals versus Small Molecule
Drugs
6. 'Approaching the Same...Treatment of Diabetes
7. The Structure and Business of Bio/pharmaceutical Companies including the
Management of Risks and Resources
8. Gefitinib
9. Herceptin/T-DM1
10. Erythropoietin (Epogen/Eprex/NeoRecormon)
11. Lysosomal Storage diseases
12. Steroids for HRT
13. Anti-HIV protease inhibitor Darunavir
14. Anti-TNF Agents Remicade/Humira/Enbrel/Cimzia
15. The Cholesterol Lowering Drug - Ezetimibe